Showing 2040 results
-
Story /Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.
-
Statement /
-
Media Library / -
Story /In Cameroon, seeking treatment for chronic diseases can be a long journey.
-
In The News /Novartis reaches agreement with Pakistan to increase access to medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
-
Pulse Update /
-
Press release /Comprehensive data package demonstrates that Sandoz biosimilar pegfilgrastim matches the reference biologic in terms of safety, efficacy and quality Pegfilgrastim is a long-acting version of…
-
Statement /
-
Press release /If approved, will be first-of-a-kind biosimilar natalizumab in Europe, for use in all indications of reference biologic Positive CHMP opinion based on evidence from extensive analytical…
-
Story /We’re working to bring the hope of advanced medicine to more patients.